3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide and Dyskinesia, Drug-Induced

3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide has been researched along with Dyskinesia, Drug-Induced in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, M; Gabriele, J; Henry, P; Johnson, RL; Mishra, RK; Paladino, P; Saeedi, H; Sharma, S	1

Other Studies

1 other study(ies) available for 3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide and Dyskinesia, Drug-Induced

Article	Year
Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia. Peptides, 2003, Volume: 24, Issue:2 Topics: Administration, Oral; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Haloperidol; Humans; Injections; Male; Mastication; MSH Release-Inhibiting Hormone; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Time Factors	2003

Article

Year

Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia.

Peptides, 2003, Volume: 24, Issue:2

Topics: Administration, Oral; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Haloperidol; Humans; Injections; Male; Mastication; MSH Release-Inhibiting Hormone; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Time Factors

2003